RootsAnalysis is pleased to announce the publication of its recent study, titled,“Global Autoinjectors Market, 2021-2030.”
Thereport features an extensive study of the current market landscape, offering aninformed opinion on the likely adoption of autoinjectors over the next decade.The report features an in-depth analysis, highlighting the diverse capabilitiesof stakeholders engaged in this domain. In addition to other elements, thestudy includes:
· A detailed assessment of the current marketlandscape of developers engaged in the development and / or manufacturingautoinjectors.
· A detailed assessment of current landscape ofcompanies that are developing drugs in combination with autoinjectors.
· A competitiveness analysis of variousdisposable and reusable autoinjectors.
· A detailed brand positioning analysis ofleading industry players highlighting the current perceptions regarding theirproprietary brands.
· A list of marketed drugs / therapies andpipeline candidates that are likely to be developed in combination withautoinjectors in the near future.
· A list of key opinion leaders (KOLs) withinthis domain with significant contributions in clinical trials and filing patentapplications.
· Detailed case studies on the most commonlytargeted indications of the approved autoinjector products.
· A case study on the role of CMOs offeringservices for drug delivery devices.
· A SWOT analysis capturing the key parametersand trends that are likely to influence the future of autoinjectors market.
· Elaborate profiles of autoinjectormanufacturers that have more than three devices in their respective product portfolios.
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
Requestfor Customization @ AutoinjectorsMarket Size
Usability
· Disposable
· Reusable
Routeof Administration
· Subcutaneous
· Intramuscular
Typeof Molecule
· Monoclonal Antibody
· Peptide
· Protein
· Small Molecule
TherapeuticIndication
· Anaphylaxis
· Asthma
· Multiple Sclerosis
· Rheumatoid Arthritis
· Migraine
· Diabetes
· Other Indications
KeyGeographies
· North America
· Europe
· Asia-Pacific
· Rest of the World
Theresearch, analysis and insights presented in this report are backed by a deepunderstanding of key insights gathered from both secondary and primaryresearch. The opinions and insights presented in the report were influenced bydiscussions held with several players in this industry. The study includesdetailed transcripts of discussions held with the following individuals:
· David Daily (CEO and Co-founder, DALI MedicalDevices)
· Dennis Lee (Senior Program Officer in CMC,Bill & Melinda Gates Foundation)
· Douglas Marenzi (Managing Director, PHCInjection Technologies)
· Tsachi Shaked (Senior Marketing and BDDirector, Injectable Drug Delivery Devices, Elcam Medical)
· Jesse Fourt (Design Director, IDEO)
Keycompanies covered in the report
· Antares Pharma
· Consort Medical (Previously Bespak)
· DALI Medical Devices
· Elcam Medical (E3D Elcam Drug DeliveryDevices)
· Jiangsu Delfu Medical Devices
· Oval Medical Technologies
· Owen Mumford
· SHL Group
· Union Medico®
· Ypsomed
Askfor Sample @ AutoinjectorsMarket Trends
ChapterOutlines
Chapter2 providesan executive summary of the insights captured in our research. It offers ahigh-level view on the likely evolution of the autoinjectors market in theshort-mid term and long term.
Chapter3 providesa general overview of various devices that enable self-administration of drugs,specifically focusing on autoinjectors. The chapter features a discussion on thehistorical evolution of autoinjectors, along with details related to theirindividual components, device categories and associated manufacturing /packaging processes. In addition, it elaborates on the benefits ofautoinjectors that have led to their growing adoption over the last severalyears. The chapter also highlights the existing concerns related to needlestickinjuries and the various preventive laws that have been passed worldwide, foraddressing the pressing need for introducing advanced safety features in suchdevices.
Chapter4 isan overview of the various types of primary drug containers that are utilizedin autoinjectors. It features information on current trends related to the use of prefilled syringes and cartridges.In addition, it lists the diverse types of primary drug containers that areavailable in the market, along with details on companies that are involved inthe production of such containers.
Chapter5 providesinformation on close to 80 autoinjectors that have already been developed orare under development. It features a comprehensive analysis of these devicesbased on different parameters, such as primary drug container used (cartridge,prefilled syringe and vial), volume, device usability (disposable andreusable), route of administration (intramuscular, intradermal andsubcutaneous) and other technical parameters. In addition, the chapter providesinformation on manufacturers, along with information on year of establishment,location of headquarters and strength of employee base.
AlsoVisit Our Latest Publication
In Silico / Computer-Aided DrugDiscovery Services Market
Antibody Contract Manufacturing Market
Biopharma Contract Manufacturing Market
Cell Therapy Manufacturing Market
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
